🔴 Pyxis Oncology is trading 5% down with no company-specific announcement identified

Pyxis Oncology is trading at $1.71 (-5.00%), with no clear company-specific announcement explaining the decline.

• No company-specific announcement on October 16 explains the move; the latest release listed on its investor-relations page is dated October 2.
• Biotech is down 2.06% amid rotation away from risk-sensitive growth stocks.
• The wider market is mixed; sector weakness is the more relevant context, not a confirmed direct cause.